Subfatin, Asprosin, Alamandine and Maresin-1 Inflammation Molecules in Cardiopulmonary Bypass

References

• Levy H, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75(2):S715–S720. doi:10.1016/s0003-475(02)04701-x
   PubMed Web of Science ®Google Scholar
• Aydin S, Aydin S, Nesimi Eren M, et al. The cardiovascular system and the biochemistry of grafts used in heart surgery. Springerplus. 2013;2(1):612. doi:10.1186/2193-1801-2-612
   PubMedGoogle Scholar
• Foley JH, Conway EM. Cross talk pathways between coagulation and inflammation. Circ Res. 2016;118(9):1392–1408. doi:10.1161/CIRCRESAHA.116.306853
   PubMed Web of Science ®Google Scholar
• Mallat Z, Binder CJ. The why and how of adaptive immune responses in ischemic cardiovascular disease. Nat Cardiovascular Res. 2022;1(5):431–444. doi:10.1038/s44161-022-00049-1
   PubMedGoogle Scholar
• Corral-Velez V, Lopez-Delgado JC, Betancur-Zambrano NL, et al. The inflammatory response in cardiac surgery: an overview of the pathophysiology and clinical implications. Inflamm Allergy Drug Targets. 2015;13(6):367–370. doi:10.2174/1871528114666150529120801
   PubMedGoogle Scholar
• Ding X, Chang X, Wang J, et al. Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile. Front Endocrinol. 2022;13:938341. doi:10.3389/fendo.2022.938341
   PubMed Web of Science ®Google Scholar
• Ushach I, Burkhardt AM, Martinez C, et al. METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin Immunol. 2015;156(2):119–127. doi:10.1016/j.clim.2014.11.006
   PubMed Web of Science ®Google Scholar
• Huang S, Cao L, Cheng H, et al. The blooming intersection of subfatin and metabolic syndrome. Rev Cardiovasc Med. 2021;22(3):799–805. doi:10.31083/j.rcm2203086
   PubMed Web of Science ®Google Scholar
• Mirzaoglu M, Yavuzkir S, Mirzaoglu C, et al. Use of asprosin and subfatin for differential diagnosis of serous ovarian tumors. Biotech Histochem. 2023;98(2):140–146. doi:10.1080/10520295.2022.2135763
   PubMed Web of Science ®Google Scholar
• Cheng JX, Yu K. New discovered adipokines associated with the pathogenesis of obesity and type 2 diabetes. Diabetes Metab Syndr Obes. 2022;15:2381–2389. doi:10.2147/DMSO.S376163
   PubMed Web of Science ®Google Scholar
• Akbulut T, Cinar V, Ugur K, Yardim M, Karagoz ZK, Aydin S. Effect of regular exercise on the levels of subfatin and asprosin: a trial with different types of exercise. Eur Rev Med Pharmacol Sci. 2022;26(8):2683–2691. doi:10.26355/eurrev_202204_28598
   PubMed Web of Science ®Google Scholar
• Deng B, Wang CW, Arnardottir HH, et al. Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages. PLoS One. 2014;9(7):e102362. doi:10.1371/journal.pone.0102362
   PubMed Web of Science ®Google Scholar
• Tang S, Wan M, Huang W, Stanton RC, Xu Y. Maresins: specialized proresolving lipid mediators and their potential role in inflammatory-related diseases. Mediators Inflamm. 2018;2018:2380319. doi:10.1155/2018/2380319
   PubMed Web of Science ®Google Scholar
• Wang CW, Yu SH, Fretwurst T, et al. Maresin 1 promotes wound healing and socket bone regeneration for alveolar ridge preservation. J Dent Res. 2020;99(8):930–937. doi:10.1177/0022034520917903
   PubMed Web of Science ®Google Scholar
• Theofilis P, Sagris M, Oikonomou E, et al. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021;9(7):781. doi:10.3390/biomedicines9070781
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Sharma A, Chen M, Toy R, Mottola G, Conte MS. The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells. PLoS One. 2014;9(11):e113480. doi:10.1371/journal.pone.0113480
   PubMed Web of Science ®Google Scholar
• Saito-Sasaki N, Sawada Y, Nakamura M. Maresin-1 and inflammatory disease. Int J Mol Sci. 2022;23(3):1367. doi:10.3390/ijms23031367
   PubMedGoogle Scholar
• Adachi Y, Ueda K, Nomura S, et al. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling. Nat Commun. 2022;13(1):5117. doi:10.1038/s41467-022-32658-6
   PubMed Web of Science ®Google Scholar
• Romere C, Duerrschmid C, Bournat J, et al. Asprosin, a Fasting-induced glucogenic protein hormone. Cell. 2016;165(3):566–579. doi:10.1016/j.cell.2016.02.063
   PubMed Web of Science ®Google Scholar
• Chen ZX, Jia WN, Jiang YX. Genotype-phenotype correlations of Marfan syndrome and related fibrillinopathies: phenomenon and molecular relevance. Front Genet. 2022;13:943083. doi:10.3389/fgene.2022.943083
   PubMed Web of Science ®Google Scholar
• Duerrschmid C, He Y, Wang C, et al. Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017;23(12):1444–1453. doi:10.1038/nm.4432
   PubMed Web of Science ®Google Scholar
• Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: a novel player in metabolic diseases. Front Endocrinol. 2020;11:64. doi:10.3389/fendo.2020.00064
   PubMed Web of Science ®Google Scholar
• Lee T, Yun S, Jeong JH, Jung TW. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Mol Cell Endocrinol. 2019;486:96–104. doi:10.1016/j.mce.2019.03.001
   PubMed Web of Science ®Google Scholar
• Wiecek M, Szymura J, Sproull J, Szygula Z. Decreased blood asprosin in hyperglycemic menopausal women as a result of whole-body cryotherapy regardless of metabolic syndrome. J Clin Med. 2019;8(9):1428. doi:10.3390/jcm8091428
   PubMed Web of Science ®Google Scholar
• Almeida-Santos AF, de Melo LA, Gonçalves SCA, et al. Alamandine through MrgD receptor induces antidepressant-like effect in transgenic rats with low brain angiotensinogen. Horm Behav. 2021;127:104880. doi:10.1016/j.yhbeh.2020.104880
   PubMed Web of Science ®Google Scholar
• Hrenak J, Paulis L, Simko F. Angiotensin A/Alamandine/MrgD Axis: another clue to understanding cardiovascular pathophysiology. Int J Mol Sci. 2016;17(7):1098. doi:10.3390/ijms17071098
   PubMed Web of Science ®Google Scholar
• de Carvalho Santuchi M, Dutra MF, Vago JP, et al. Angiotensin-(1-7) and Alamandine promote anti-inflammatory response in macrophages in vitro and in vivo. Mediators Inflamm. 2019;2019:2401081. doi:10.1155/2019/2401081
   PubMed Web of Science ®Google Scholar
• de Souza-Neto FP, Silva MME, Santuchi MC, et al. Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice. Clin Sci. 2019;133(5):629–643. doi:10.1042/CS20180547
   Web of Science ®Google Scholar
• Aydin S, Catak Z, Eren MN, Topal AE, Aydin S. Irisin in Coronary Bypass Surgery. Cardiovasc Hematol Disord Drug Targets. 2018;18(3):208–214. doi:10.2174/1871529X18666180511141151
   PubMedGoogle Scholar
• Aydin S. A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides. 2015;72:4–15. doi:10.1016/j.peptides.2015.04.012
   PubMed Web of Science ®Google Scholar
• Li J, Zhang H, Zhang C. Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications. J Mol Cell Cardiol. 2012;52(4):865–872. doi:10.1016/j.yjmcc.2011.08.027
   PubMed Web of Science ®Google Scholar
• Kobiyama K, Ley K. Atherosclerosis. Circ Res. 2018;123(10):1118–1120. doi:10.1161/CIRCRESAHA.118.313816
   PubMed Web of Science ®Google Scholar
• Liu M, He H, Chen L. Protective potential of maresins in cardiovascular diseases. Front Cardiovasc Med. 2022;9:923413. doi:10.3389/fcvm.2022.923413
   PubMed Web of Science ®Google Scholar
• Cezar TLC, Martinez RM, da Rocha C, et al. Treatment with maresin 1, a docosahexaenoic acid-derived pro-resolution lipid, protects skin from inflammation and oxidative stress caused by UVB irradiation. Sci Rep. 2019;9(1):3062. doi:10.1038/s41598-019-39584-6
   PubMedGoogle Scholar
• Sánchez-Fernández A, Zandee S, Mastrogiovanni M, et al. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2022;19(1):27. doi:10.1186/s12974-022-02386-1
   PubMed Web of Science ®Google Scholar
• Moradi N, Fouani FZ, Vatannejad A, Bakhti Arani A, Shahrzad S, Fadaei R. Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study. Lipids Health Dis. 2021;20(1):88. doi:10.1186/s12944-021-01514-9
   PubMed Web of Science ®Google Scholar
• Güven C, Kafadar H. Evaluation of plasma asprosin concentration in patients with coronary artery disease. Braz J Cardiovasc Surg. 2022;37(4):493–500. doi:10.21470/1678-9741-2021-0003
   PubMed Web of Science ®Google Scholar
• Fujii T, Hirai T, Tamura T, Suzuki S, Nishiwaki K. Effect of intensive insulin therapy on inflammatory response after cardiac surgery using bedside artificial pancreas: a propensity score-matched analysis. Artif Organs. 2023;47(6):982–989. doi:10.1111/aor.14418
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI. Asprosin-a fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature. Nutrients. 2021;13(2):620. doi:10.3390/nu13020620
   PubMed Web of Science ®Google Scholar
• Reyes-Umpierrez D, Davis G, Cardona S, et al. Inflammation and oxidative stress in cardiac surgery patients treated to intensive versus conservative glucose targets. J Clin Endocrinol Meta. 2017;102(1):309–315. doi:10.1210/jc.2016-3197
   PubMed Web of Science ®Google Scholar
• Song XD, Feng JP, Yang RX. Alamandine protects rat from myocardial ischemia-reperfusion injury by activating JNK and inhibiting NF-κB. Eur Rev Med Pharmacol Sci. 2019;23(15):6718–6726. doi:10.26355/eurrev_201908_18563
   PubMed Web of Science ®Google Scholar
• Silva MM, de Souza-Neto FP, de Jesus ICG, et al. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice. Am J Physiol Heart Circ Physiol. 2021;320(1):H352–H363. doi:10.1152/ajpheart.00328.2020
   PubMed Web of Science ®Google Scholar